printemailclick to share buttonfacebooktwitterlinkedin
Radiation Therapy Evidence-based Series (EBS)

The Radiation Therapy Evidence-based Series are produced by Expert Panels convened by Cancer Care Ontario that work together with the PEBC to gather and examine evidence on specific topics related to radiation therapy treatment in Ontario. The reports produced by these panels are available below.

The PEBC has a formal and standardized process to ensure the currency of each document (please see the PEBC Assessment & Review Protocol for more information). This process guides clinical experts to assess a document’s current status and relevance. A final status statement is added to the document when this review process is complete. The current status of each guidance document is noted beside the title and link as outlined below:

  • Documents listed as CURRENT are 3 years old or less, up-to-date, and can be used for decision making.
  • Documents listed as IN REVIEW are undergoing assessment for currency and relevance.  The DSG/GDG has determined that it is still appropriate for this document to continue to be available while this updating process unfolds.
  • Documents that are listed as “FOR EDUCATION AND INFORMATION PURPOSES” are documents for which no further updates are planned and whose recommendations may no longer be consistent with recent evidence.  They may be of educational, historical, clinical, or system interest.

If you have any questions regarding a document that is “In Review,” please contact the PEBC ( or the lead author of the document.

  • Brachytherapy for Patients with Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update
    Guideline 3-A-2016-1
    Status: CURRENT
    The clinical practice guideline is an ASCO-CCO collaboration, produced by a joint expert panel convened by the ASCO Clinical Practice Guidelines Committee and the CCO Program in Evidence-Based Care.
  • Radiotherapy with Curative Intent in Patients with Early Stage, Medically Inoperative, Non-Small Cell Lung Cancer
    Guideline 7-21: May, 2016
    Status: CURRENT

For Education and Information Purposes

  • The Delivery of Brachytherapy for Cervical Cancer: Organizational and Technical Advice to Facilitate High-Quality Care in Ontario
  • Radiopharmaceuticals for the Palliation of Painful Bone Metastases
  • The Role of IMRT In Prostate Cancer
  • The Role of IMRT In Breast Cancer
  • The Role of IMRT In Head & Neck Cancer
  • The Role of IMRT in Central Nervous System Cancer
  • The Role of IMRT In Lung Cancer
  • The Role of IMRT in Soft-Tissue Sarcomas
  • The Role of IMRT In Gynecologic Cancers
  • The Role of IMRT In Thyroid Cancers
  • The Role of IMRT in Skin Cancers
  • The Role of IMRT in Gastrointestinal Cancers
  • Organizational Standards for the Delivery of Intensity Modulated Radiation Therapy (IMRT) in Ontario
Program in Evidence-Based Care (PEBC)
McMaster University, Juravinski Site
G Wing, 2nd Floor
711 Concession Street
Hamilton, Ontario, Canada
L8V 1C3

Phone: 905.527.4322 ext. 42822
Fax: 905.526.6775
Last modified: Tue, Mar 28, 2017
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?